Australia's ImpediMed hits one-month low after posting annual loss

ImpediMed

29/08/2022 05:31

** Shares of medical software technology co ImpediMed Ltd
 IPD.AX  fall as much as 5.6% to A$0.067, lowest since July 28
    ** Co records FY22 net loss attributable of A$19.9 mln 
($13.65 mln), compared with a loss of A$20.7 mln in FY21
 urn:newsml:reuters.com:*:nFWN303062 
    ** Co does not propose a dividend for the year
    ** Says received lower proceeds from tax incentives and
government grants in FY22 and faced increase in staff costs 
    ** Posts FY22 revenue from ordinary activities of A$10.6
mln, compared with A$8.4 mln in FY21
    ** Shares of co down 59.4% YTD, as of last close 

    
($1 = 1.4575 Australian dollars)

 (Reporting by John Biju)
 ((John.Biju@thomsonreuters.com;))